Skip to content
Peptigraph home

Semax vs Selank: What the Research Shows

Semax and Selank side by side: what they are, how they are regulated and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
ACTH(4-10) analogPCAC voted 8–5 for 503A (Jul 2026)SemaxSynthetic ACTH-fragment analog tested in small, mostly Russian trials; in one controlled study ulcer healing occurred in 89.5% of patients versus 30.8% of controls by day 14.[5]Cognitive & sleepTuftsin analogNot FDA approved · research chemicalSelankSynthetic tuftsin analog tested in small, mostly Russian trials; in one randomized comparison its anxiolytic effect was similar to an active comparator drug.[19]Cognitive & sleep
Quick verdict

Where the research points

Summary of studies, not a recommendation

Consider Semax if…

  • you want controlled-trial data (a small peptic-ulcer trial): Ulcer healing at day 14 occurred in 89.5% of patients on intranasal semax versus 30.8% of controls.[5]
  • you want controlled-trial data in ischemic stroke patients: Semax raised plasma BDNF levels, which stayed high through the study.[3]

Consider Selank if…

  • you want randomized anxiety data (versus medazepam): Anxiolytic effects of selank and medazepam were similar; selank also showed antiasthenic and psychostimulant effects.[19]

What they have in common

  • A human study in 52 healthy participants compared Selank and Semax effects on brain connectivity (an imaging measure, not a clinical outcome)[16]
Neither is FDA approved for any use in people. Status labels come from public FDA and WADA records; see the sources below.
Side by side

Spec comparison

Showing 7 of 11 fields where the two differ. Category, WADA, Half-life, Evidence strength are the same or both unknown.

FieldSemaxSelank
ClassACTH(4-10) analogTuftsin analog
Also calledsemax nasal—
FDA statusPCAC voted 8–5 for 503A (Jul 2026)Not FDA approved · research chemical
PCAC vote, Jul 2026PCAC voted 8–5 for the 503A list (Jul 2026); not finalizedNot on the Jul 2026 agenda
Human studies we summarised6 human (5 randomized or controlled) of 15 summarised4 human (3 randomized or controlled) of 15 summarised
Typical study doses
Vial sizes sold5 mg, 10 mg, 30 mg5 mg, 10 mg

Bracketed values are pending a sourced figure. Legal data reflects the regulatory events in our tracker.

Taken together?

Semax and Selank together

People also search for this pair as a stack. The stack page covers timing and interaction questions as they are sourced. Evidence for the combination: 3 published studies included both (PMID 32342318, 28702721, 11443939).

Open the stack page

The few places they have been tested together

The one human head-to-head is a brain-imaging study in 52 healthy volunteers who received Semax, Selank or placebo; it measured connectivity, not mood or memory.[16]

Both peptides altered the same circuit, between the right amygdala and temporal-lobe regions, with some effects shared and some specific to each.[16]

In a rat model of Parkinson-like damage, only Selank reduced anxiety-like behaviour, while neither changed movement.[17]

In human serum, both peptides slowed the enzymes that break down enkephalins, with Semax the more potent of the two.[18]

Different targets in patients

Selank's patient trials target anxiety: in one randomised trial its anxiolytic effect was similar to a benzodiazepine, with extra anti-fatigue effects.[19]

A controlled Selank trial reported that the calming effect outlasted treatment, persisting for a week after the last dose.[23]

Semax's patient trials are in neurology and eye and gut conditions rather than anxiety: a stroke study showed raised BDNF and better Barthel scores.[3]

Semax also has a peptic-ulcer trial in which most treated patients had healed ulcers by day 14, compared with a minority of controls.[5]

A Semax follow-up in patients after oxygen deprivation noted a cautionary safety point: some showed abnormal EEG activity after the first injection.[24]

Route, regulation and sport rules

In a rat comparison of routes, Semax improved learning more strongly when given through the nose than by injection.[25]

FDA's compounding review says it lacks important safety information on selank in people.[26]

For Semax, the same review reports little or no safety information for the routes proposed.[26]

Neither has an FDA record; the approvals-database search for Selank returned nothing.[27]

Common questions

Is Semax or Selank better for anxiety?

Selank has the anxiety trials, where it performed similarly to a benzodiazepine in one randomised study; Semax's trials are in other conditions.[19]

Is Semax or Selank better for focus and memory?

The human head-to-head used imaging only and found shared and distinct network effects; no study compares them on a memory test.[16]

Can you take Semax and Selank together?

No trial tests the pair as a regimen; the nearest data are single-injection imaging comparisons in volunteers.[16]

Are Semax and Selank FDA approved?

No; the FDA approvals database search for Semax returned nothing.[28]

Sources

  1. 1FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
  2. 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  3. 3[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018PMID 29798983Accessed 2 Oct 2026
  4. 4Effects of Semax on the Default Mode Network of the Brain.Bulletin of experimental biology and medicine · 2018PMID 30225715Accessed 2 Oct 2026
  5. 5Therapy of peptic ulcer with semax peptide.Bulletin of experimental biology and medicine · 2002PMID 12459874Accessed 2 Oct 2026
  6. 6PubMed search: semax[tiab] (208 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: semax[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: (selank[tiab] OR semax[tiab]) AND (randomized[tiab] OR patients[tiab] OR clinical[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9[Optimization of the treatment of anxiety disorders with selank].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2015PMID 26356395Accessed 2 Oct 2026
  10. 10Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.Bulletin of experimental biology and medicine · 2019PMID 31625062Accessed 2 Oct 2026
  11. 11[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].Eksperimental'naia i klinicheskaia farmakologiia · 2016PMID 29787664Accessed 2 Oct 2026
  12. 12[Experimental optimization of learning and memory processes by selank].Eksperimental'naia i klinicheskaia farmakologiia · 2010PMID 20919548Accessed 2 Oct 2026
  13. 13PubMed search: selank[tiab] (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: selank[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: (selank[tiab]) AND (semax[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16Functional Connectomic Approach to Studying Selank and Semax Effects.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020PMID 32342318Accessed 2 Oct 2026
  17. 17Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2017PMID 28702721Accessed 2 Oct 2026
  18. 18[Semax and selank inhibit the enkephalin-degrading enzymes from human serum]].Bioorganicheskaia khimiia · 2001PMID 11443939Accessed 2 Oct 2026
  19. 19[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008PMID 18454096Accessed 2 Oct 2026
  20. 20Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
  21. 21PubMed search: semax[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (17 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  22. 22PubMed search: selank[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  23. 23[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
  24. 24[Use of semax at a follow-up of patients with posthypoxic encephalopathy].Anesteziologiia i reanimatologiia · 1999PMID 10199046Accessed 2 Oct 2026
  25. 25[Nootropic and analgesic effects of Semax following different routes of administration].Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2010PMID 21268834Accessed 2 Oct 2026
  26. 26Official web pageOfficial web page · web page
  27. 27Drugs@FDA (openFDA) search: active ingredient "selank"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  28. 28Drugs@FDA (openFDA) search: active ingredient "semax"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026

Found an error? Report a correction.